Management of Sphincter Dyssynergia Using the Sphincter Stent Prosthesis in Chronically Catheterized SCI Men

Mb, Chancellor; Da, Rivas; Ck, Abdill; We, Staas; Cj, Bennett; Mv, Finocchiaro; Razi, Salman S.; Jk, Bennett; Bg, Green; Je, Foote

doi:10.1080/10790268.1995.11719384

Cited by 15 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sphincter prosthesis placement reduces signi®cantly voiding pressure and residual urine volume without adverse e ect on bladder capacity. 23 In our clinical experience many SCI patients with DESD prefer the stent because it is potentially reversible. Renal and erectile function were not negatively altered after prosthesis and hydronephrosis may be resolved or stabilized in all patients.…”

Section: Discussionmentioning

confidence: 97%

Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia

et al. 1999

View full text Add to dashboard Cite

This study is an analysis of the Memotherm 1 prosthesis in spinal cord injured patients with Detrusor-external sphincter dyssynergia (DESD). Twenty-four patients were evaluated urodynamically before and after placement of the intraurethral stent prosthesis. All the patients had been chronically managed with an indwelling urinary catheter, intermittent catheterization or condom catheters. Sixty-six per cent had history of recurrent urinary tract infection, 37% had symptoms of autonomic dysre¯exia. Nine patients had previous external sphincterotomy.Follow-up ranged from 3 ± 39 months (mean 15.4 months). After stent insertion all patients were able to achieve spontaneous re¯ex voiding with the use of condom catheter. Postoperative urodynamics parameters bladder leak point pressure and residual urine volume decreased signi®cantly after stent insertion. Stent insertion was accomplished without any operative complications. In four patients stent migration (16%) required telescoping a new system over the migrated stent. In two patients the stent was removed because of problems of infection and calculus formation.In conclusion, this system (Memotherm 1 ) is an attractive, and potentially reversible treatment for DESD in SCI patients.

show abstract

Section: Discussionmentioning

confidence: 97%

Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia

et al. 1999

View full text Add to dashboard Cite

show abstract

“…17 It has also been recently demonstrated that this improved bladder emptying is associated with reduction of bladder voiding pressures, which also decreases urologic and nephrologic complications.…”

mentioning

confidence: 99%

Outcome after treatment of detrusor–sphincter dyssynergia by temporary stent

et al. 2007

View full text Add to dashboard Cite

Objectives: To evaluate follow-up treatments used after treatment of detrusor-sphincter dyssynergia (DSD) by a temporary urethral sphincter stent. Materials and methods: Between February 1994 and June 2003, 147 men with a mean age of 41.3714.4 years were treated by temporary urethral stent inserted across the external sphincter for DSD. The underlying neurologic disease was quadriplegia in 85 cases, multiple sclerosis in 24 cases and paraplegia in 21 cases. A Nissenkorn (Bard) stent was used in 130 cases and a Diabolo (Porgès) stent was used in 17 cases. All patients were either unable to or they refused to perform intermittent selfcatheterization. DSD was demonstrated by urodynamic studies in every case. Results: The mean duration of temporary stenting was 10.15716.07 months. After temporary stenting, 92 patients were treated by permanent stent (Ultraflex, Boston Scientifics), 7 started intermittent self-catheterization, 12 had repeated changes of the temporary stent, 4 had an indwelling catheter, 3 underwent cystectomy with non-continent diversion, 2 were treated by endoscopic sphincterotomy, 1 was treated by bladder neck incision, 1 was treated by neuromodulation and 1 was treated by cystostomy. Fifteen patients were lost to follow-up. Two patients died during follow-up (not related to DSD). Conclusion: After treatment of DSD by a temporary urethral sphincter stent, 70.7% of patients subsequently require a permanent urethral sphincter stent. This period allows selection of patients unlikely to benefit from permanent urethral sphincter stent.

show abstract

Traitement chirurgical de la dysurie et de la rétention par dysfonctionnement sphinctérien neurogéne

Chartier-Kästler¹,

Ayoub²,

Mozer³

et al.

Collection De L’Académie Européenne De Médecine De Réadaptation

View full text Add to dashboard Cite

Management of Sphincter Dyssynergia Using the Sphincter Stent Prosthesis in Chronically Catheterized SCI Men

Cited by 15 publications

References 0 publications

Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia

Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia

Outcome after treatment of detrusor–sphincter dyssynergia by temporary stent

Traitement chirurgical de la dysurie et de la rétention par dysfonctionnement sphinctérien neurogéne

Contact Info

Product

Resources

About